GRIA4 and colorectal carcinoma: However, in order to enhance future applications, it would be advantageous to conduct a comparative analysis between plasma and stool samples for the GRIA4 methylation detection of CRC, as stool-based tests utilizing SEPT9 methylation have demonstrated superior performance compared to plasma-based tests (58, 59).